2022.04.19
Drug Repurposing for the Identification of Compounds with Anti-SARS-CoV-2 Capability via Multiple Targets
This work is published on Pharmaceutics in January, 2022. It is a cooperation with Prof. Hsueh-Fen Juan from Department of Life Science and Institute of Molecular and Cellular Biology, NTU.
The BSL-3 Research and Analysis Laboratory helped to determine the EC50 of these selected compounds against authentic SARS-CoV-2 variants via plaque reduction assay.
2022.04.19
Neutralizing Monoclonal Antibodies Inhibit SARS-CoV-2 Infection through Blocking Membrane Fusion
This work is published on Microbiology Spectrum in March, 2022. It is a cooperation with Prof. Shih-Chung Chang from Department of Biochemical Science and Technology, NTU.
The BSL-3 Research and Analysis Laboratory helped to perform and analyze the neutralization ability of monoclonal antibodies against authentic SARS-CoV-2 variants.
2022.04.19
A siRNA targets and inhibits a broad range of SARS-CoV-2 infections including Delta variant
This work is published on EMBO Molecular Medicine in February, 2022. It is a cooperation with Prof. Pan-Chyr Yang from Department of Internal Medicine, National Taiwan University Hospital, and Oneness Biotech. Co., Ltd..
The BSL-3 Research and Analysis Laboratory helped to screen and confirm the efficiency of siRNA against authentic SARS-CoV-2 variants.